Structure-Based Antiviral Drugs and Vaccine Design
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 114
Special Issue Editors
Interests: viral entry and antiviral entry; viral vaccines; filoviruses; retroviruses
Special Issues, Collections and Topics in MDPI journals
Interests: flavivirus; mosquito transmitted virus; antiviral; vaccine; viral pathogenesis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to promote studies on drug and vaccine design and development against viral diseases using structure-based approaches including AI-powered technologies. Certainly, it is more rational to utilize their structural relations for designs such as between receptors and ligands or antigens and antibodies. In recent years, AI-incorporated structure-based designing programs have significantly enhanced design efficiency and effectiveness. We would like to encourage and publish these data by using innovative technologies in antiviral therapeutics and preventive vaccines. The articles will be included in basic research in vitro, in vivo, and clinical studies.
Dr. Shi-hua Xiang
Prof. Dr. Fengwei Bai
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antiviral
- structure based
- AI-powered
- drug design
- vaccine design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
